Journal of Pharmaceutical and Biomedical Analysis 2014-11-01

Development of a method to quantify the DNA content in cationic peptide-DNA nanoparticles.

Arvind K Jain, Helmy Yusuf, Aditya Pattani, Helen O McCarthy, Denise M McDonald, Vicky L Kett

Index: J. Pharm. Biomed. Anal. 100 , 236-42, (2014)

Full Text: HTML

Abstract

Gene therapy has the potential to provide safe and targeted therapies for a variety of diseases. A range of intracellular gene delivery vehicles have been proposed for this purpose. Non-viral vectors are a particularly attractive option and among them cationic peptides have emerged as promising candidates. For the pharmaceutical formulation and application to clinical studies it is necessary to quantify the amount of pDNA condensed with the delivery system. There is a severe deficiency in this area, thus far no methods have been reported specifically for pDNA condensed with cationic peptide to form nanoparticles. The current study seeks to address this and describes the evaluation of a range of disruption agents to extract DNA from nanoparticles formed by condensation with cationic fusogenic peptides RALA and KALA. Only proteinase K exhibited efficient and reproducible results and compatibility with the PicoGreen reagent based quantification assay. Thus we report for the first time a simple and reliable method that can quantify the pDNA content in pDNA cationic peptide nanoparticles. Copyright © 2014 Elsevier B.V. All rights reserved.